Lexaria Bioscience Corp.

NASDAQ: LEXX · Real-Time Price · USD
0.80
0.00 (0.13%)
At close: Aug 15, 2025, 3:59 PM
0.82
2.44%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lexaria Bioscience Income Statement

Financials in USD. Fiscal year is September - August.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Aug 31, 2024 Aug 31, 2023 Aug 31, 2022 Aug 31, 2021
Revenue
464.28K 226.21K 255.4K 722.74K
Cost of Revenue
4.82K 31.5K 71.84K 175.35K
Gross Profit
459.46K 194.71K 183.56K 547.39K
Operating Income
-5.75M -6.53M -7.38M -5.69M
Interest Income
14.31K 43.19K n/a n/a
Pretax Income
-5.81M -6.71M -7.38M -4.16M
Net Income
-5.8M -6.66M -7.27M -2.5M
Selling & General & Admin
3.85M 3.06M 5.72M 4.97M
Research & Development
2.36M 3.67M 1.84M 1.26M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
6.21M 6.73M 7.57M 6.23M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
6.22M 6.76M 7.64M 6.41M
Income Tax Expense
n/a n/a -114.33K -1.66M
Shares Outstanding (Basic)
12.38M 6.61M 5.89M 4.39M
Shares Outstanding (Diluted)
12.38M 6.61M 5.89M 4.39M
EPS (Basic)
-0.47 -1.01 -1.24 -0.57
EPS (Diluted)
-0.47 -1.01 -1.24 -0.57
EBITDA
-5.68M -6.39M -6.52M -5.58M
EBIT
-5.75M -6.53M -6.62M -5.69M
Depreciation & Amortization
76.15K 145.4K 146.91K 147.6K